Ciprofol vs Propofol for Hemodynamic Stability in Patients Having General Anesthesia for Endovascular Thrombectomy After Ischemic Stroke

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 124 participants.

Also called NCT07696208

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 124 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07696208
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07696208. Randomized; double masking; primary purpose treatment. Start 2026-07-01 (anticipated); primary completion 2028-01-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Ciprofol vs Propofol for Hemodynamic Stability in Patients Having General Anesthesia for Endovascular Thrombectomy After Ischemic Stroke
Condition
Hemodynamic Stability
Intervention (Drug)
Ciprofol
Intervention (Drug)
Propofol
Lead sponsor
RenJi Hospital (class: other)
Collaborator
Haisco Pharmaceutical Group Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct07696208
Content hash
20bad0c7f5107c55ce8ebc325a1be1196d54a04d909c5683d8fec8bbe616e58b